Jan Kenneth Gonzales
Nurse Practitioner · Lake City, FLNPI 1043820376
Payments from drug & device makers
Across 200 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$462
- Boehringer Ingelheim$389
- AbbVie$357
- Astellas Pharma US Inc$253
- AstraZeneca$249
- Merck$214
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,29795%
- Education$1755%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 28 | $462 |
| Boehringer Ingelheim | 23 | $389 |
| AbbVie | 28 | $357 |
| Astellas Pharma US Inc | 7 | $253 |
| AstraZeneca | 15 | $249 |
| Merck | 13 | $214 |
| Mylan Specialty L.p. | 7 | $153 |
| Lilly USA, LLC | 9 | $144 |
| Pfizer | 8 | $127 |
| Amarin Pharma, Inc. | 6 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Bayer | 5 | $90 |
| Johnson & Johnson | 5 | $85 |
| Nestle Healthcare Nutrition Inc. | 4 | $79 |
| Radius Health, Inc. | 3 | $65 |
| Dexcom, Inc. | 3 | $58 |
| Sanofi-aventis U.S. LLC | 2 | $48 |
| Exact Sciences | 3 | $46 |
| Biohaven Pharmaceuticals, Inc. | 2 | $46 |
| Amgen | 3 | $44 |
| GSK | 3 | $40 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Sunovion Pharmaceuticals Inc. | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Novartis | 2 | $32 |
| Biogen | 2 | $31 |
| Eisai Inc. | 2 | $31 |
| Medtronic | 1 | $30 |
| Grifols USA, LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
| Otsuka America Pharmaceutical, Inc. | 1 | $12 |
How this compares
$3,472 in reported general payments places this provider in the 85th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 100 | $164,951 |
| FarxigaDapagliflozin Propanediol | 147 | $149,500 |
| JardianceEmpagliflozin | 89 | $99,702 |
| EliquisApixaban | 92 | $95,597 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 91 | $82,725 |
| XareltoRivaroxaban | 45 | $62,103 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 14 | $57,923 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 55 | $47,037 |
| VascepaIcosapent Ethyl | 56 | $42,122 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 50 | $35,568 |
| MyrbetriqMirabegron | 34 | $32,937 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 54 | $31,806 |
| MounjaroTirzepatide | 29 | $30,453 |
| LinzessLinaclotide | 33 | $28,152 |
| TrulicityDulaglutide | 19 | $26,424 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $249 | $214,803249 claims |
| Novo NordiskOzempic, Rybelsus | $462 | $186,622111 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $389 | $131,508143 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $40 | $126,512152 claims |
| PfizerEliquis | $127 | $95,59792 claims |
| Johnson & JohnsonXarelto | $85 | $62,10345 claims |
| Lilly USA, LLCMounjaro, Trulicity | $144 | $56,87748 claims |
| AbbVieLinzess, Creon, Synthroid | $357 | $48,60572 claims |
| Astellas Pharma US IncMyrbetriq | $253 | $32,93734 claims |
| NovartisEntresto | $32 | $22,66123 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $96 | $15,47423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Lake City
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.